Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Quantifying Asymptomatic Infection and Transmission of COVID-19 in New York City using Observed Cases, Serology and Testing Capacity

View ORCID ProfileRahul Subramanian, View ORCID ProfileQixin He, View ORCID ProfileMercedes Pascual
doi: https://doi.org/10.1101/2020.10.16.20214049
Rahul Subramanian
aDepartment of Ecology and Evolution, Biological Sciences Division, University of Chicago, Chicago, IL 60637
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Rahul Subramanian
Qixin He
aDepartment of Ecology and Evolution, Biological Sciences Division, University of Chicago, Chicago, IL 60637
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Qixin He
Mercedes Pascual
aDepartment of Ecology and Evolution, Biological Sciences Division, University of Chicago, Chicago, IL 60637
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Mercedes Pascual
  • For correspondence: pascualmm@uchicago.edu
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Supplementary material
  • Data/Code
  • Preview PDF
Loading

Abstract

The contributions of asymptomatic infections to herd immunity and community transmission are key to the resurgence and control of COVID-19, but are difficult to estimate using current models that ignore changes in testing capacity. Using a model that incorporates daily testing information fit to the case and serology data from New York City, we show that the proportion of symptomatic cases is low, ranging from 13% to 18%, and that the reproductive number may be larger than often assumed. Asymptomatic infections contribute substantially to herd immunity, and to community transmission together with pre-symptomatic ones. If asymptomatic infections transmit at similar rates than symptomatic ones, the overall reproductive number across all classes is larger than often assumed, with estimates ranging from 3.2 to 4.4. If they transmit poorly, then symptomatic cases have a larger reproductive number ranging from 3.9 to 8.1. Even in this regime, pre-symptomatic and asymptomatic cases together comprise at least 50% of the force of infection at the outbreak peak. We find no regimes in which all infection sub-populations have reproductive numbers lower than 3. These findings elucidate the uncertainty that current case and serology data cannot resolve, despite consideration of different model structures. They also emphasize how temporal data on testing can reduce and better define this uncertainty, as we move forward through longer surveillance and second epidemic waves. Complementary information is required to determine the transmissibility of asymptomatic cases, which we discuss. Regardless, current assumptions about the basic reproductive number of SARS-Cov-2 should be reconsidered.

Significance Statement As health officials face another wave of COVID-19, they require estimates of the proportion of infected cases that develop symptoms, and the extent to which symptomatic and asymptomatic cases contribute to community transmission. Recent asymptomatic testing guidelines are ambiguous. Using an epidemiological model that includes testing capacity, we show that most infections are asymptomatic but contribute substantially to community transmission in the aggregate. Their individual transmissibility remains uncertain. If they transmit as well as symptomatic infections, the epidemic may spread at faster rates than current models often assume. If they do not, then each symptomatic case generates on average a higher number of secondary infections than typically assumed. Regardless, controlling transmission requires community-wide interventions informed by extensive, well-documented asymptomatic testing.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

RS was supported by an National Science Foundation Research Traineeship-Number 1735359-NRT-INFEWS-Computational data science to advance research at the energy environment nexus. This work was completed with resources and support provided by the University of Chicago Research Computing Center.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

NA

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • RS: Conceptualization, Data curation, Formal Analysis, Methodology, Writing-original draft; QH: Conceptualization, Writing-review and editing; MP: Conceptualization, Methodology, Writing-review and editing, Project administration.

  • The authors declare no competing interests.

Data Availability

Original data created for the study are or will be available in a persistent repository upon publication.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted October 20, 2020.
Download PDF

Supplementary Material

Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Quantifying Asymptomatic Infection and Transmission of COVID-19 in New York City using Observed Cases, Serology and Testing Capacity
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Quantifying Asymptomatic Infection and Transmission of COVID-19 in New York City using Observed Cases, Serology and Testing Capacity
Rahul Subramanian, Qixin He, Mercedes Pascual
medRxiv 2020.10.16.20214049; doi: https://doi.org/10.1101/2020.10.16.20214049
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Quantifying Asymptomatic Infection and Transmission of COVID-19 in New York City using Observed Cases, Serology and Testing Capacity
Rahul Subramanian, Qixin He, Mercedes Pascual
medRxiv 2020.10.16.20214049; doi: https://doi.org/10.1101/2020.10.16.20214049

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Epidemiology
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (172)
  • Anesthesia (51)
  • Cardiovascular Medicine (456)
  • Dentistry and Oral Medicine (83)
  • Dermatology (55)
  • Emergency Medicine (160)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (192)
  • Epidemiology (5317)
  • Forensic Medicine (3)
  • Gastroenterology (199)
  • Genetic and Genomic Medicine (767)
  • Geriatric Medicine (81)
  • Health Economics (216)
  • Health Informatics (704)
  • Health Policy (364)
  • Health Systems and Quality Improvement (224)
  • Hematology (100)
  • HIV/AIDS (166)
  • Infectious Diseases (except HIV/AIDS) (5971)
  • Intensive Care and Critical Care Medicine (368)
  • Medical Education (107)
  • Medical Ethics (25)
  • Nephrology (83)
  • Neurology (781)
  • Nursing (43)
  • Nutrition (135)
  • Obstetrics and Gynecology (147)
  • Occupational and Environmental Health (237)
  • Oncology (483)
  • Ophthalmology (155)
  • Orthopedics (40)
  • Otolaryngology (98)
  • Pain Medicine (39)
  • Palliative Medicine (20)
  • Pathology (141)
  • Pediatrics (224)
  • Pharmacology and Therapeutics (138)
  • Primary Care Research (99)
  • Psychiatry and Clinical Psychology (868)
  • Public and Global Health (2051)
  • Radiology and Imaging (356)
  • Rehabilitation Medicine and Physical Therapy (160)
  • Respiratory Medicine (288)
  • Rheumatology (96)
  • Sexual and Reproductive Health (75)
  • Sports Medicine (77)
  • Surgery (110)
  • Toxicology (25)
  • Transplantation (30)
  • Urology (40)